Search - tctmd.com

Displaying 201 - 214 of 214

Sort: Relevancy | Date

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Daily News

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Caitlin E. Cox

June 15, 2015

News Industry News

TAVR program raises margin 350% by befriending rivals

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

European TAVR Usage Tied to Economics, Reimbursement

Yael L. Maxwell

July 12, 2013

News Daily News

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

Yael L. Maxwell

July 12, 2013

News Daily News

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

L.A. McKeown

October 14, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

Advertisement

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

TAVR program raises margin 350% by befriending rivals

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

European TAVR Usage Tied to Economics, Reimbursement

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

PARTNER: TAVI Cost Effective Compared With Standard Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content